• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

听觉神经病损部位的客观判定

Objective Determination of Site-of-Lesion in Auditory Neuropathy.

作者信息

Zanin Julien, Rance Gary

机构信息

Department of Audiology and Speech Pathology, The University of Melbourne, Parkville, Melbourne, Australia.

The HEARing Cooperative Research Centre, Melbourne, Victoria, Australia.

出版信息

Ear Hear. 2025;46(2):371-381. doi: 10.1097/AUD.0000000000001589. Epub 2024 Sep 19.

DOI:10.1097/AUD.0000000000001589
PMID:39294863
Abstract

OBJECTIVES

Auditory neuropathy (AN), a complex hearing disorder, presents challenges in diagnosis and management due to limitations of current diagnostic assessment. This study aims to determine whether diffusion-weighted magnetic resonance imaging (MRI) can be used to identify the site and severity of lesions in individuals with AN.

METHODS

This case-control study included 10 individuals with AN of different etiologies, 7 individuals with neurofibromatosis type 1 (NF1), 5 individuals with cochlear hearing loss, and 37 control participants. Participants were recruited through the University of Melbourne's Neuroaudiology Clinic and the Murdoch Children's Research Institute specialist outpatient clinics. Diffusion-weighted MRI data were collected for all participants and the auditory pathways were evaluated using the fixel-based analysis metric of apparent fiber density. Data on each participant's auditory function were also collected including hearing thresholds, otoacoustic emissions, auditory evoked potentials, and speech-in-noise perceptual ability.

RESULTS

Analysis of diffusion-weighted MRI showed abnormal white matter fiber density in distinct locations within the auditory system depending on etiology. Compared with controls, individuals with AN due to perinatal oxygen deprivation showed no white matter abnormalities ( p > 0.05), those with a neurodegenerative conditions known/predicted to cause VIII cranial nerve axonopathy showed significantly lower white matter fiber density in the vestibulocochlear nerve ( p < 0.001), while participants with NF1 showed lower white matter fiber density in the auditory brainstem tracts ( p = 0.003). In addition, auditory behavioral measures of speech perception in noise and gap detection were correlated with fiber density results of the VIII nerve.

CONCLUSIONS

Diffusion-weighted MRI reveals different patterns of anatomical abnormality within the auditory system depending on etiology. This technique has the potential to guide management recommendations for individuals with peripheral and central auditory pathway abnormality.

摘要

目的

听觉神经病(AN)是一种复杂的听力障碍,由于当前诊断评估的局限性,在诊断和管理方面存在挑战。本研究旨在确定弥散加权磁共振成像(MRI)是否可用于识别AN患者的病变部位和严重程度。

方法

本病例对照研究纳入了10例病因不同的AN患者、7例1型神经纤维瘤病(NF1)患者、5例耳蜗性听力损失患者和37名对照参与者。参与者通过墨尔本大学神经听力学诊所和默多克儿童研究所专科门诊招募。收集了所有参与者的弥散加权MRI数据,并使用基于固定点分析的表观纤维密度指标评估听觉通路。还收集了每位参与者的听觉功能数据,包括听力阈值、耳声发射、听觉诱发电位和噪声中的言语感知能力。

结果

弥散加权MRI分析显示,根据病因不同,听觉系统内不同位置的白质纤维密度异常。与对照组相比,围产期缺氧所致AN患者未显示白质异常(p>0.05),已知/预测会导致第八颅神经轴突病的神经退行性疾病患者在前庭蜗神经中的白质纤维密度显著降低(p<0.001),而NF1患者在听觉脑干束中的白质纤维密度较低(p=0.003)。此外,噪声中的言语感知和间隙检测的听觉行为测量结果与第八神经的纤维密度结果相关。

结论

弥散加权MRI根据病因揭示了听觉系统内不同的解剖学异常模式。该技术有可能为外周和中枢听觉通路异常的个体指导管理建议。

相似文献

1
Objective Determination of Site-of-Lesion in Auditory Neuropathy.听觉神经病损部位的客观判定
Ear Hear. 2025;46(2):371-381. doi: 10.1097/AUD.0000000000001589. Epub 2024 Sep 19.
2
Fiber-Specific Changes in White Matter Microstructure in Individuals With X-Linked Auditory Neuropathy.纤维特异性改变在 X 连锁遗传性感觉神经性聋患者的白质微观结构。
Ear Hear. 2020 Nov/Dec;41(6):1703-1714. doi: 10.1097/AUD.0000000000000890.
3
Auditory Dysfunction Among Individuals With Neurofibromatosis Type 1.听觉功能障碍在 1 型神经纤维瘤病患者中的表现。
JAMA Netw Open. 2021 Dec 1;4(12):e2136842. doi: 10.1001/jamanetworkopen.2021.36842.
4
Diffusion-Weighted Magnetic Resonance Imaging: A Diagnostic Tool for Auditory (Axonal) Neuropathy.扩散加权磁共振成像:听觉(轴索性)神经病的诊断工具。
Eur J Neurol. 2025 Feb;32(2):e70083. doi: 10.1111/ene.70083.
5
OPA1-related auditory neuropathy: site of lesion and outcome of cochlear implantation.OPA1相关听觉神经病:病变部位及人工耳蜗植入效果
Brain. 2015 Mar;138(Pt 3):563-76. doi: 10.1093/brain/awu378. Epub 2015 Jan 5.
6
Auditory neuropathy/dys-synchrony and its perceptual consequences.听觉神经病/失同步及其感知后果。
Trends Amplif. 2005;9(1):1-43. doi: 10.1177/108471380500900102.
7
Evaluation and therapy outcome in children with auditory neuropathy spectrum disorder (ANSD).听觉神经病谱系障碍(ANSD)患儿的评估与治疗结果
Int J Pediatr Otorhinolaryngol. 2019 Dec;127:109681. doi: 10.1016/j.ijporl.2019.109681. Epub 2019 Sep 13.
8
[Otoacoustic emissions, auditory evoked potentials, pure tone thresholds and speech intelligibility in cases of auditory neuropathy].[听觉神经病患者的耳声发射、听觉诱发电位、纯音听阈及言语清晰度]
HNO. 2000 Jan;48(1):28-32. doi: 10.1007/s001060050005.
9
"Auditory neuropathy": physiologic and pathologic evidence calls for more diagnostic specificity.“听觉神经病”:生理和病理证据要求更高的诊断特异性。
Int J Pediatr Otorhinolaryngol. 2003 Jul;67(7):707-28. doi: 10.1016/s0165-5876(03)00103-4.
10
Cortical processing of speech in individuals with auditory neuropathy spectrum disorder.听觉神经病谱系障碍患者的言语皮层加工
Eur Arch Otorhinolaryngol. 2018 Jun;275(6):1409-1418. doi: 10.1007/s00405-018-4966-8. Epub 2018 Apr 9.